Abstract
Advances in understanding cancer at the molecular level have identified numerous genomic and proteomic alterations associated with cancer development and progression. The efforts in evaluating these putative biomarkers in clinical studies of patients with cancer are increasing, reflecting the great
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have